Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli

Biotechnol Lett. 2016 Apr;38(4):651-7. doi: 10.1007/s10529-015-2017-8. Epub 2015 Dec 22.

Abstract

Objectives: To evaluate the combination of a culture medium employing glucoamylase-mediated glucose reléase from a gluco-polysaccharide and an E. coli strain engineered in its glucose transport system for improving plasmid DNA (pDNA) production.

Results: The production of pDNA was tested using E. coli DH5α grown in shake-flasks and the recently developed VH33 Δ(recA deoR)-engineered strain, which utilizes glucose more efficiently than wild type strains. Three glucoamylase concentrations for releasing glucose from the polysaccharide carbon source were used: 1, 2 and 3 U l(-1). Both strains reached similar cell densities ranging from 5 to 8.8 g l(-1) under the different conditions. The highest pDNA yields on biomass (YpDNA/X) for both strains were obtained when 3 U enzyme l(-1)were used. Under these conditions, 35 ± 3 mgof pDNA l(-1) were produced by DH5α after 24 h of culture. Under the same conditions, the engineered strain produced 66 ± 1 mgpDNAl(-1) after 20 h. pDNA supercoiled fractionswere close to 80 % for both strains.

Conclusions: The pDNA concentration achieved by the engineered E. coli was 89 % higher than that of DH5α. The combination of the engineered strain and enzyme-controlled glucose release is an attractive alternative for pDNA production in shake-flasks.

Keywords: Galactose permease; Glucoamylase (for glucose release); Glucose release; Metabolic engineering; pDNA vaccines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Batch Cell Culture Techniques
  • Escherichia coli / genetics
  • Escherichia coli / growth & development*
  • Escherichia coli Proteins / genetics
  • Glucose / metabolism*
  • Metabolic Engineering
  • Mutation
  • Plasmids / genetics*
  • Vaccines, DNA / biosynthesis

Substances

  • Escherichia coli Proteins
  • Vaccines, DNA
  • Glucose